May 11 (Reuters)-
Takara Bio Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2018 Mar 31, 2017 Mar 31, 2019 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 32.31 29.38 36.80 17.76
(+10.0 pct) (-1.2 pct) (+13.9 pct) (+25.7 pct)
Operating 3.56 3.20 5.00 2.50
(+11.0 pct) (+20.1 pct) (+40.6 pct) (+263.1 pct)
Recurring 3.86 3.58 5.20 2.56
(+7.9 pct) (+8.4 pct) (+34.6 pct) (+233.8 pct)
Net
Net 2.34 1.35 3.10 1.65
(+72.6 pct) (+1.4 pct) (+32.8 pct) (+444.1 pct)
EPS 19.39 yen 11.24 yen 25.74 yen 13.68 yen
Ann Div 4.50 yen 4.00 yen 6.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 4.50 yen 4.00 yen 6.00 yen
NOTE - Takara Bio Inc..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T